Springer Protocols: Abstract: Tissue Microdissection

Tissue Microdissection

By: Heidi S. Erickson³, John W. Gillespie⁴, Michael R. Emmert-Buck³

Abstract

Full Text

Download PDF (491K)

Procurement of pure populations of cells from heterogeneous histological sections can be accomplished utilizing tissue microdissection. At present, a variety of different manual and laser-based dissection tools are available and each method has particular strengths and weaknesses. The types of biomolecular analyses that can be performed on microdissected cells depend not only on the method of cell procurement, but also on the effects of upstream tissue handling and processing. Tissue preparation protocols include two major approaches; snap-freezing, or, fixation and embedding. Snap-freezing generally provides the best quality tissue for subsequent study, including proteomic analyses such as two-dimensional polyacrylamide gel electrophoresis (2D-PAGE). Tissue fixatives include either precipitating reagents or biomolecular cross-linkers. The fixed samples are then further processed and embedded in a wax medium. In general, the biomolecules recovered from fixed and embedded tissue specimens are lower in both quantity and quality than those from snap-frozen specimens, although they are useful for certain types of analyses. The protocols provided here for tissue handling and processing, preparation of tissue sections, and microdissection are derived from our experience at the Pathogenetics Unit of the National Cancer Institute.

Affiliation(s): (3) National Institutes of Health, Bethesda, Maryland
(4) National Cancer Institute at Frederick, Frederick, Maryland

Book Title: 2D PAGE: Sample Preparation and Fractionation

Series: Methods in Molecular Biology | Volume: 424 | Pub. Date: Jan-25-2008 | Page Range: 433-448 | DOI: 10.1007/978-1-60327-064-9_34

Subject: Genetics/Genomics

Key Words: Laser capture microdissection - LCM - microdissection - slide preparation - tissue

References

Download References

1.	Radford, D. M., Fair, K., Thompson, A. M., Ritter, J. H. et al. (1993) Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast. Cancer Res 53, 2947–9.

2.	Emmert-Buck, M. R., Roth, M. J., Zhuang, Z., Campo, E. et al. (1994) Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol 145, 1285–90.

3.	Koreth, J., Bethwaite, P. B., McGee, J. O. (1995) Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis. J Pathol 176, 11–8.

4.	Speiser, P., Gharehbaghi-Schnell, E., Schneeberger, C., Eder, S. et al. (1996) Microdissection as a means to verify allelic imbalance in tumour biology samples. Anticancer Res 16, 461–4.

5.	Zhuang, Z., Merino, M. J., Chuaqui, R., Liotta, L. A. et al. (1995b) Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res 55, 467–71.

6.	Chuaqui, R. F., Zhuang, Z., Emmert-Buck, M. R., Liotta, L. A. et al. (1997b) Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. Am J Pathol 150, 297–303.

7.	Quezado, M. M., Moskaluk, C. A., Bryant, B., Mills, S. E. et al. (1999) Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma. Hum Pathol 30, 203–7.

8.	Rubin, M. A. (2002) Tech.Sight. Understanding disease cell by cell. Science 296, 1329–30.

9.	Emmert-Buck, M. R., Bonner, R. F., Smith, P. D., Chuaqui, R. F. et al. (1996) Laser capture microdissection. Science 274, 998–1001.

10.	Bonner, R. F., Emmert-Buck, M., Cole, K., Pohida, T. et al. (1997) Laser capture microdissection: molecular analysis of tissue. Science 278, 1481, 1483.

11.	Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E. et al. (1997) Gene expression profiles in normal and cancer cells. Science 276, 1268–72.

12.	Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C. et al. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531–7.

13.	Klose, J. (1999) Genotypes and phenotypes. Electrophoresis 20, 643–52.

14.	Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C. et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–11.

15.	Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M. et al. (2000) Molecular portraits of human breast tumours. Nature 406, 747–52.

16.	Strausberg, R. L., Buetow, K. H., Emmert-Buck, M. R., Klausner, R. D. (2000) The cancer genome anatomy project: building an annotated gene index. Trends Genet 16, 103–6.

17.	Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M. et al. (2001) Gene-expression profiles in hereditary breast cancer. N Engl J Med 344, 539–48.

18.	Swalwell, J. I., Vocke, C. D., Yang, Y., Walker, J. R. et al. (2002) Determination of a minimal deletion interval on chromosome band 8p21 in sporadic prostate cancer. Genes Chromosomes Cancer33, 201–5.

19.	Emmert-Buck, M. R., Vocke, C. D., Pozzatti, R. O., Duray, P. H. et al. (1995) Allelic loss on chromosome 8p12–21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 55, 2959–62.

20.	Thiberville, L., Payne, P., Vielkinds, J., LeRiche, J. et al. (1995) Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res 55, 5133–9.

21.	Chuaqui, R. F., Englert, C. R., Strup, S. E., Vocke, C. D. et al. (1997) Identification of a novel transcript up-regulated in a clinically aggressive prostate carcinoma. Urology 50, 302–7.

22.	Fearon, E. R., Hamilton, S. R., Vogelstein, B. (1987) Clonal analysis of human colorectal tumors. Science 238, 193–7.

23.	Shibata, D., Hawes, D., Li, Z. H., Hernandez, A. M. et al. (1992) Specific genetic analysis of microscopic tissue after selective ultraviolet radiation fractionation and the polymerase chain reaction. Am J Pathol 141, 539–43.

24.	Schena, M., Shalon, D., Davis, R. W., Brown, P. O. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467–70.

25.	Chee, M., Yang, R., Hubbell, E., Berno, A. et al. (1996) Accessing genetic information with high-density DNA arrays. Science 274, 610–4.

26.	DeRisi, J., Penland, L., Brown, P. O., Bittner, M. L. et al. (1996) Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 14, 457–60.

27.	Going, J. J. and Lamb, R. F. (1996) Practical histological microdissection for PCR analysis. J Pathol 179, 121–4.

28.	Moskaluk, C. A. and Kern, S. E. (1997) Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am J Pathol 150, 1547–52.

29.	Schena, M., Heller, R. A., Theriault, T. P., Konrad, K. et al. (1998) Microarrays: biotechnology's discovery platform for functional genomics. Trends Biotechnol 16, 301–6.

30.	Simone, N. L., Bonner, R. F., Gillespie, J. W., Emmert-Buck, M. R. et al. (1998) Laser-capture microdissection: opening the microscopic frontier to molecular analysis. Trends Genet 14, 272–6.

31.	Celis, J. E., Kruhoffer, M., Gromova, I., Frederiksen, C. et al. (2000) Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics. FEBS Lett 480, 2–16.

32.	Leethanakul, C., Patel, V., Gillespie, J., Shillitoe, E. et al. (2000) Gene expression profiles in squamous cell carcinomas of the oral cavity: use of laser capture microdissection for the construction and analysis of stage-specific cDNA libraries. Oral Oncol 36, 474–83.

33.	Ornstein, D. K., Cinquanta, M., Weiler, S., Duray, P. H. et al. (2001) Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium. J Urol 165, 1329–34.

34.	Best, C. J., Leiva, I. M., Chuaqui, R. F., Gillespie, J. W. et al. (2003) Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis. Diagn Mol Pathol 12, 63–70.

35.	Best, C. J., Gillespie, J. W., Yi, Y., Chandramouli, G. V. et al. (2005) Molecular alterations in primary prostate cancer after androgen ablation therapy. Clin Cancer Res 11, 6823–34.

36.	Lockhart, D. J., Dong, H., Byrne, M. C., Follettie, M. T. et al. (1996) Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14, 1675–80.

37.	Zhuang, Z., Bertheau, P., Emmert-Buck, M. R., Liotta, L. A. et al. (1995) A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size. Am J Pathol 146, 620–5.

38.	Emmert-Buck, M. R., Gillespie, J. W., Paweletz, C. P., Ornstein, D. K. et al. (2000) An approach to proteomic analysis of human tumors. Mol Carcinog 27, 158–65.

39.	Ornstein, D. K., Gillespie, J. W., Paweletz, C. P., Duray, P. H. et al. (2000) Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis 21, 2235–42.

40.	Knezevic, V., Leethanakul, C., Bichsel, V. E., Worth, J. M. et al. (2001) Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 1, 1271–8.

41.	Wulfkuhle, J. D., McLean, K. C., Paweletz, C. P., Sgroi, D. C. et al. (2001) New approaches to proteomic analysis of breast cancer. Proteomics 1, 1205–15.

42.	Wulfkuhle, J. D., Sgroi, D. C., Krutzsch, H. et al. (2002) Proteomics of Human Breast Ductal Carcinoma in Situ. Cancer Res 62, 6740–49.

43.	Wulfkuhle, J. D., Liotta, L. A., Petricoin, E. F. (2003) Proteomic applications for the early detection of cancer. Nat Rev Cancer 3, 267–75.

44.	Ahram, M., Best, C. J., Flaig, M. J., Gillespie, J. W. et al. (2002) Proteomic analysis of human prostate cancer. Mol Carcinog 33, 9–15.

45.	Craven, R. A., Totty, N., Harnden, P., Selby, P. J. et al. (2002) Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitations. Am J Pathol 160, 815–22.

46.	Jones, M. B., Krutzsch, H., Shu, H., Zhao, Y. et al. (2002) Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics2, 76–84.

47.	Ornstein, D. K., Englert, C., Gillespie, J. W., Paweletz, C. P. et al. (2000) Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium. Clin Cancer Res6, 353–6.

48.	OLeiva, I. M., Emmert-Buck, M. R., Gillespie, J. W. (2003) Handling of clinical tissue specimens for molecular profiling studies. Curr Issues Mol Biol5, 27–3.

49.	Posadas, E. M., Simpkins, F., Liotta, L. A., MacDonald, C. et al. (2005) Proteomic analysis for the early detection and rational treatment of cancer–-realistic hope? Ann Oncol 16, 16–22.

50.	Paweletz, C. P., Charboneau, L., Bichsel, V. E., Simone, N. L. et al.(2001) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20, 1981–9.

51.	Simone, N. L., Paweletz, C. P., Charboneau, L., Petricoin, E. F. 3rd et al. (2000) Laser capture microdissection: beyond functional genomics to proteomics. Mol Diagn 5, 301–7.

52.	Simone, N. L., Remaley, A. T., Charboneau, L., Petricoin, E. F. 3rd et al. (2000) Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection. Am J Pathol 156, 445–52.

53.	Herrmann, P. C., Gillespie, J. W., Charboneau, L., Bichsel, V. E. et al. (2003 ) Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer. Proteomics 3, 1801–10.

54.	Zhou, G., Li, H., DeCamp, D., Chen, S. et al. (2002) 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol Cell Proteomics 1, 117–24.

55.	Gillespie, J. W., Best, C. J., Bichsel, V. E., Cole, K. A. et al. (2002) Evaluation of non-formalin tissue fixation for molecular profiling studies. Am J Pathol 160, 449–57.

56.	Gillespie, J. W., Gannot, G., Tangrea, M. A., Ahram, M. et al. (2004) Molecular profiling of cancer. Toxicol Pathol 32 Suppl 1, 67–71.

57.	Ahram, M., Flaig, M. J., Gillespie, J. W., Duray, P. H. et al. (2003) Evaluation of ethanol-fixed, paraffin-embedded tissues for proteomic applications. Proteomics 3, 413–21.

58.	Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F. et al. (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17, 994–9.

59.	Gorg, A., Obermaier, C., Boguth, G., Harder, A. et al. (2000) The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21, 1037–53.

60.	Gygi, S. P. and Aebersold, R. (2000) Mass spectrometry and proteomics. Curr Opin Chem Biol 4, 489–94.

61.	Hanash, S. M. (2000) Biomedical applications of two-dimensional electrophoresis using immobilized pH gradients: current status. Electrophoresis 21, 1202–9.

62.	Best, C. J. and Emmert-Buck, M. R. (2001) Molecular profiling of tissue samples using laser capture microdissection. Expert Rev Mol Diagn 1, 53–60.

63.	Tangrea, M. A., Chuaqui, R. F., Gillespie, J. W., Ahram, M. et al. (2004) Expression microdissection: operator-independent retrieval of cells for molecular profiling. Diagn Mol Pathol 13, 207–12.

64.	Hanson, J. A., Gillespie, J. W., Grover, A., Tangrea, M. A. et al. (2006) Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst 98, 255–61.

65.	Grover, A. C., Tangrea, M. A., Woodson, K. G., Wallis, B. S. et al. (2006) Tumor-associated endothelial cells display GSTP1 and RARbeta2 promoter methylation in human prostate cancer. J Transl Med 4, 13.

66.	Paweletz, C.P., Gillespie, J.W., et al. (2000) Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip. Drug Development Research 49, 34–42.

67.	Stoeckli, M., Chaurand, P., Hallahan, D. E., Caprioli, R. M. (2001) Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med 7, 493–6.

68.	Chaurand, P. and Caprioli, R. M. (2002) Direct profiling and imaging of peptides and proteins from mammalian cells and tissue sections by mass spectrometry. Electrophoresis 23, 3125–35.

69.	Yanagisawa, K., Shyr, Y., Xu, B. J., Massion, P. P. et al. (2003) Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 362, 433–9.

70.	Schwartz, S. A., Weil, R. J., Johnson, M. D., Toms, S. A. et al. (2004) Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression. Clin Cancer Res 10, 981–7.

71.	Adam, B. L., Qu, Y., Davis, J. W., Ward, M. D. et al. (2002) Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 62, 3609–14.

72.	Li, J., Zhang, Z., Rosenzweig, J., Wang, Y. Y. et al. (2002) Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48, 1296–304.

73.	Petricoin, E. F. 3rd, Ornstein, D. K., Paweletz, C. P., Ardekani, A. et al. (2002) Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 94, 1576–8.

74.	Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V. et al. (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437–50.

Comments (Loading...)

Post comment/View all comments